Louisiana State Employees Retirement System Takes Position in Solventum Corporation $SOLV

Louisiana State Employees Retirement System bought a new position in Solventum Corporation (NYSE:SOLV) during the 1st quarter, Holdings Channel reports. The fund bought 7,500 shares of the company’s stock, valued at approximately $490,000.

A number of other hedge funds also recently made changes to their positions in SOLV. Assetmark Inc. grew its holdings in Solventum by 21.4% during the 4th quarter. Assetmark Inc. now owns 725 shares of the company’s stock valued at $57,000 after buying an additional 128 shares in the last quarter. Hilltop National Bank raised its holdings in shares of Solventum by 71.3% during the 4th quarter. Hilltop National Bank now owns 310 shares of the company’s stock worth $25,000 after acquiring an additional 129 shares in the last quarter. Allworth Financial LP raised its holdings in shares of Solventum by 2.8% during the 3rd quarter. Allworth Financial LP now owns 4,788 shares of the company’s stock worth $350,000 after acquiring an additional 129 shares in the last quarter. CIBC Private Wealth Group LLC boosted its position in shares of Solventum by 0.5% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 24,710 shares of the company’s stock valued at $1,804,000 after acquiring an additional 134 shares during the last quarter. Finally, BOKF NA boosted its position in shares of Solventum by 6.9% during the 3rd quarter. BOKF NA now owns 2,193 shares of the company’s stock valued at $160,000 after acquiring an additional 141 shares during the last quarter.

Solventum Price Performance

NYSE:SOLV opened at $75.29 on Thursday. The firm has a market capitalization of $13.04 billion, a price-to-earnings ratio of 9.23, a PEG ratio of 1.18 and a beta of 0.66. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.07 and a quick ratio of 0.75. The business has a 50 day simple moving average of $75.87 and a 200-day simple moving average of $74.34. Solventum Corporation has a 1 year low of $62.38 and a 1 year high of $88.20.

Solventum (NYSE:SOLV) last released its earnings results on Tuesday, May 5th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.35 by $0.13. Solventum had a return on equity of 23.51% and a net margin of 17.33%.The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the previous year, the company posted $1.34 EPS. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 6.600-6.600 EPS. Equities analysts forecast that Solventum Corporation will post 6.58 EPS for the current year.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. BMO Capital Markets began coverage on shares of Solventum in a report on Wednesday. They issued a “market perform” rating and a $81.00 target price for the company. Wedbush began coverage on shares of Solventum in a research note on Friday, May 15th. They set an “outperform” rating and a $94.00 price target on the stock. Rothschild & Co Redburn began coverage on shares of Solventum in a research report on Tuesday, March 24th. They set a “sell” rating and a $60.00 price objective for the company. Stifel Nicolaus dropped their price objective on shares of Solventum from $105.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. Finally, Weiss Ratings downgraded shares of Solventum from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, June 26th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $83.50.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.